Cargando…
Inhibition of α-hemolysin activity of Staphylococcus aureus by theaflavin 3,3’-digallate
The ongoing rise in antibiotic resistance, and a waning of the introduction of new antibiotics, has resulted in limited treatment options for bacterial infections, including these caused by methicillin-resistant Staphylococcus aureus, leaving the world in a post-antibiotic era. Here, we set out to e...
Autores principales: | Goc, Anna, Sumera, Waldemar, Rath, Matthias, Niedzwiecki, Aleksandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470925/ https://www.ncbi.nlm.nih.gov/pubmed/37651426 http://dx.doi.org/10.1371/journal.pone.0290904 |
Ejemplares similares
-
Inhibitory effect of theaflavin-3,3′-digallate can involve its binding to the “stem” domain of α-hemolysin of Staphylococcus aureus
por: Goc, Anna, et al.
Publicado: (2023) -
Antibacterial and Sporicidal Activity Evaluation of Theaflavin-3,3′-digallate
por: Yussof, Ayuni, et al.
Publicado: (2022) -
Identification of Theaflavin-3,3’-Digallate as a Novel Zika Virus Protease Inhibitor
por: Cui, Xiangling, et al.
Publicado: (2020) -
Microbial Metabolism of Theaflavin-3,3′-digallate
and Its Gut Microbiota Composition Modulatory Effects
por: Liu, Zhibin, et al.
Publicado: (2020) -
Theaflavin-3,3′-Digallate Protects Cartilage from Degradation by Modulating Inflammation and Antioxidant Pathways
por: Teng, Yun, et al.
Publicado: (2022)